Cameco Corp. (0R35)
London Exchange · UK · prices in CAD · close of 15 Oct 2026
Key indicators
| Last close | CAD 117.38 |
|---|---|
| 52-week range | 111.76 – 182.68 |
| Return, 1 month / 3 months | −8.3% / −8.0% |
| Return, 1 year / 3 years | −8.6% / +138.8% |
| Trend | Below its 200-day average |
| RSI (14) | 38 |
| Volatility (1 year) | 56.3% |
| Worst drawdown (1 year) | -34.7% |
| Average daily value traded | 0.34M CAD |
| Dividend yield | 0.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Cameco Corp. is a Canadian uranium producer and fuel services supplier based in Saskatoon, Saskatchewan. The company mines uranium ore at sites in northern Saskatchewan and processes it into concentrates, and it also refines and converts uranium for use in nuclear fuel. Its customers are electric utilities that operate nuclear power reactors, mainly in North America, Europe and Asia. Cameco provides uranium concentrates, conversion services and fuel fabrication work for those reactor operators.
The shares are listed on the London Exchange in UK under the code 0R35, and the price on this page is in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Cameco Corp. (0R35) trades on the London Exchange in UK. It last closed at CAD 117.38 on 15 October 2026.
Its price-based Market X-Ray is 29 out of 100 (a weak price profile), ranking 3,129 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 8.6% and over the last three months it fell 8.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 21 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -19.4% | ||
| From 52-week high | -34.4% | ||
| Momentum | 29 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -8.0% | ||
| 6-month return | -28.1% | ||
| 12-month return, skipping the last month | -0.3% | ||
| Stability (higher is calmer) | 31 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 56.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.7% | ||
| Liquidity | 42 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.34M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 21 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.2% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −4.6% |
|---|---|
| 1 month | −8.3% |
| 3 months | −8.0% |
| 6 months | −28.1% |
| 1 year | −8.6% |
| 3 years | +138.8% |
| 5 years | +273.4% |
Signals
| 50-day / 200-day average | 132.21 / 145.70 |
|---|---|
| Golden / death cross (60 days) | Death, 56 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.37 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Dec 2025 | CAD 0.2400 |
| 27 Nov 2024 | CAD 0.1600 |
| 29 Nov 2023 | CAD 0.1200 |
| 29 Nov 2022 | CAD 0.1200 |
| 29 Nov 2021 | CAD 0.0800 |
| 27 Nov 2020 | CAD 0.0800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.